ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy’s, Alvotech to co-develop Keytruda biosimilar
Dr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of Keytruda, a highly successful cancer drug. This partnership aims to provide more affordable treatment options globally as Merck's pat
Announcement as on 05 June 2025

Dr Reddy's gets 2 observations from USFDA for Telangana API plant
Dr. Reddy's Laboratories received a Form 483 with two observations following a GMP inspection by the USFDA at its API manufacturing plant (CTO-5) in Miryalaguda, Telangana. The inspection, conducted from May 19 to May 24, 2025, identified potential violati
Announcement as on 25 May 2025

Dr Reddy's gets 2 observations from USFDA for New York API plant
Dr. Reddy's Laboratories announced that the USFDA issued a Form 483 with two observations after a GMP inspection of its API manufacturing facility in Middleburgh, New York. The inspection, conducted between May 12-16, 2025, identified potential violations
Announcement as on 17 May 2025

Dr Reddy's Labs Q4 Results: Cons PAT jumps 22% to Rs 1,594 crore; Rs 8 per share dividend announced
Dr Reddy's Labs Q4 Results: Dr Reddy's Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus Rs 1,307 crore reported in the year ago period.
Announcement as on 09 May 2025

Dr Reddy’s Labs Q4 Preview: PAT may jump up to 12% YoY, revenue to rise up to 18% on generics business dose
Dr Reddy’s Q4FY25 net profit is expected to grow 1.3–12% YoY, with revenues likely rising 13–18% to ₹7,981–8,424 crore, according to brokerage estimates. Key focus areas include US business and margin outlook.
Announcement as on 08 May 2025

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 11.85
  • 12Day Average: 11.91
  • 20Day Average: 12.4
  • 50Day Average: 13.23
  • 100Day Average: 13.35
  • 150Day Average: 13.55
  • 200Day Average: 13.66

RDY Indicators & signals

Indicator MACD (12,26,9)

12.07, 12.55, -0.49
Indicator MACD is in negative zone

Indicator ADX (14)

18.18, 27.27, 39.39
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Mon Aug 2026 12.07 11.95 to 12.14 1.86% 1.03 times
31 Fri Jul 2026 11.85 11.72 to 11.86 0.17% 0.89 times
30 Thu Jul 2026 11.83 11.75 to 11.87 0.6% 0.62 times
29 Wed Jul 2026 11.76 11.75 to 11.87 0.26% 0.69 times
28 Tue Jul 2026 11.73 11.60 to 11.89 -0.34% 1.22 times
27 Mon Jul 2026 11.77 11.70 to 11.88 -0.17% 1.07 times
24 Fri Jul 2026 11.79 11.68 to 11.98 0% 0.95 times
24 Fri Jul 2026 11.79 11.68 to 11.98 -0.08% 0.95 times
23 Thu Jul 2026 11.80 11.40 to 11.98 3.6% 2.16 times
22 Wed Jul 2026 11.39 11.36 to 12.54 -9.32% 1.04 times
21 Tue Jul 2026 12.56 12.39 to 12.61 0.24% 0.42 times
20 Mon Jul 2026 12.53 12.51 to 12.74 -0.56% 0.6 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top